Figure 2. Applications in treatment of common diseases model with genetically engineered CMVs. Genetically engineered CMVs work through an overexpressed proteins or nucleic acid which function as a targeting molecules, biotherapeutics, or immune modulators in therapy for tumors, systemic lupus erythematosus, diabetes, and cardiovascular diseases. CMVs: cell membrane-derived vesicles.
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.
By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection. See our privacy policy for more information on the use of your personal data.
